Please provide your email address to receive an email when new articles are posted on . Older men with higher concentrations of three bone turnover markers have a higher risk for all-cause mortality ...
A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma. Background: Aminobisphosphonates (aBP) are standard of care for myeloma related bone ...
An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which ...
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases Results from Studies of Other Investigational Merck Cancer ...
Patients with advanced solid tumors frequently experience bone metastases, which increase rates of bone turnover. Changes in bone resorption and formation can be monitored by measuring biochemical ...
Please provide your email address to receive an email when new articles are posted on . Results showed bone quality was abnormal in ankle arthritis on the affected side. However, bone quality was ...
Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater urinary calcium excretion being associated ...
GLASGOW, Scotland – A single infusion of zoledronic acid (Aclasta) prevents bone turnover in people at risk of Paget’s disease in an analysis of data from the Zoledronate in the Prevention of Paget’s ...
Treatment and clinical outcome of young (age 40 and younger) patients with advanced non-small cell lung (NSCLC). Background: Between 19 to 44% of patients with lung cancer eventually develop bone ...
Morning Overview on MSN
Study claims shocking brain bone axis link between depression and osteoporosis
For years, clinicians have noticed that people living with major depression often show unexpectedly fragile bones. What ...
A genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma (bone tumor), said scientists at the Wellcome Sanger Institute and their collaborators. The results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results